In the News

Feb 22, 2022Lauren Sciences Founder, Chairman & CEO Susan Rosenbaum and V-Smart® Platform are highlighted in Discussion Group Report, “Prominent Names in RNA Delivery Discuss What’s Around the Corner”, by Tom Cohen of Oxford Global.
Jan 19, 2021Lauren Sciences discussed on the Ozy site.
Sep 17, 2020Lauren Sciences discussed on the FightMND site.
Jul 7, 2020Lauren Sciences discussed in “Update on glioma biotechnology”, Boockvar JA et al., Clin Neurol Neurosurg. 2020 Jul 7;195:106075.
Feb 11, 2020Lauren Sciences CEO Susan Rosenbaum was interviewed by Proactive Investors at BIO CEO & Investor Conference in New York on February 11, 2020. Lauren Sciences is privately-held New York-based biotechnology company developing V-Smart® Nanomedicines to treat brain diseases. Last year it was announced that Lauren Sciences was awarded AU $1M translational grant by Australian-based FightMND.
Jun 2, 2019Lauren Sciences Won 1st Place at Global Healthcare Innovation Competition during BIO 2019 in Philadelphia, PA.
Apr 4, 2019ALS News Today article on FightMND Awards Grant to Lauren Sciences to Develop Promising ALS Therapy.
Mar 1, 2019$7.6m committed to new research projects during 2019 - FightMND.
Mar 1, 2019Neal Daniher's FightMND delivers seven new research projects - Herald Sun.
Jul 25, 2018BIO, biotechnology industry’s leading organization, announces Lauren Sciences as one of the winners at forum held during BIO’s 25th International Convention in June in Boston, MA.
Apr 18, 2018Lauren Sciences Awarded Third Grant for Development of Potential ALS Therapeutic - The ALS Association Blog.
Apr 11, 2018Lauren Sciences LLC Awarded Grant from The ALS Association - AABGU.
Mar 12, 2018Lauren Sciences "V-Smart®: A Breakthrough Innovation" is cover feature of March 2018 issue of Drug Development & Delivery magazine. Article entitled, “V-Smart® Nanomedicines: Non-Invasive Targeted Brain Therapeutics for CNS Diseases”, is authored by Susan Rosenbaum, J.D. and Irwin Hollander, Ph.D.
Dec 1, 2017The official blog of the ALS association on the highlights from the annual Society for Neuroscience meeting in Washington, D.C.